Literature DB >> 10720554

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities.

R van Crevel1, E Karyadi, F Preyers, M Leenders, B J Kullberg, R H Nelwan, J W van der Meer.   

Abstract

In tuberculosis, cellular immunity is considered to be responsible for the eradication of infection but also for damage of host tissues. In animal models, the balance between Th1-type cytokines, especially interferon (IFN)-gamma, and Th2-type cytokines, primarily interleukin (IL)-4, seems crucial for these effects. Reports on Th1-type and Th2-type cytokines in human tuberculosis are conflicting, and little is known about their role in tissue damage. Flow-cytometric assessment of cytokine responses was performed in human immunodeficiency virus (HIV)-seronegative patients with active tuberculosis and in healthy controls. Patients and controls showed no significant difference in expression of IFN-gamma. However, patients showed a striking increase in production of IL-4 in CD4+ as well as CD8+ T cells. Most remarkably, the expression of IL-4 was especially elevated in patients with cavitary tuberculosis. The Th2-type response with increased production of IL-4 in patients with tuberculosis may antagonize host defense and lead to tissue necrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720554     DOI: 10.1086/315325

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  61 in total

1.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Cytokine polarization in miliary and pleural tuberculosis.

Authors:  Surendra K Sharma; Dipender K Mitra; Arumugam Balamurugan; Ravindra M Pandey; Narinder K Mehra
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

3.  Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Authors:  Amador Goodridge; Carla Cueva; Maureen Lahiff; Grace Muzanye; John L Johnson; Payam Nahid; Lee W Riley
Journal:  Tuberculosis (Edinb)       Date:  2012-03-10       Impact factor: 3.131

4.  T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

Authors:  G Mazzarella; A Bianco; F Perna; D D'Auria; E Grella; E Moscariello; A Sanduzzi
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

5.  Microbial exposures in infancy predict levels of the immunoregulatory cytokine interleukin-4 in Filipino young adults.

Authors:  Paula Skye Tallman; Christopher Kuzawa; Linda Adair; Judith B Borja; Thomas W McDade
Journal:  Am J Hum Biol       Date:  2012-02-05       Impact factor: 1.937

6.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.

Authors:  F Abebe; T Mustafa; A H Nerland; G A Bjune
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 8.  Autophagy in the immune response to tuberculosis: clinical perspectives.

Authors:  C Ní Cheallaigh; J Keane; E C Lavelle; J C Hope; J Harris
Journal:  Clin Exp Immunol       Date:  2011-03-25       Impact factor: 4.330

Review 9.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

10.  Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens.

Authors:  A S Shahemabadi; A Zavaran Hosseini; S Shaghsempour; M R Masjedi; M Rayani; M Pouramiri
Journal:  Clin Exp Immunol       Date:  2007-05-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.